Global Biological Defense Measures 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06250061

Publication Date:

June 17, 2025

Pages:

127

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Biological Defense Measures market size is predicted to grow from US$ 17290 million in 2025 to US$ 23570 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.
Biological Defense Measure is a set of medical or military measures. These are taken in response to the demand for restoring the biosecurity of a country against biological toxins or infectious agents. The agents can be used with the intent to kill or infect humans, animals, or the environment and to instigate biological warfare. Biological agents used during bioterrorism are usually living organisms. These can include bacteria, viruses, fungi, or toxins that are deliberately used to sicken and kill creating social and economic turmoil.
Developed economies are sending aid to countries with weak medical infra and low research capabilities many companies like Bavarian Nordic and Ology Bioservices are researching Ebola and Zika virus. The introduction of the Project BioShield Act was a strategic decision to increase funding for procuring, developing, and utilizing medical countermeasures against biological, chemical, radiological, and nuclear (CBRN) warfare agents. These above-mentioned factors and the rising risk of prevalence of the infectious disease is expected to boost the market growth.
The 鈥淏iological Defense Measures Industry Forecast鈥� looks at past sales and reviews total world Biological Defense Measures sales in 2024, providing a comprehensive analysis by region and market sector of projected Biological Defense Measures sales for 2025 through 2031. With Biological Defense Measures sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Defense Measures industry.
This Insight Report provides a comprehensive analysis of the global Biological Defense Measures landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biological Defense Measures portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Biological Defense Measures market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Defense Measures and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Defense Measures.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Defense Measures market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biological
Chemical
Radiological
Nuclear (CBRN) Warfare Agents
Others
Segmentation by Application:
Medical
Military
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alnylam Pharmaceuticals Inc
Aeolus Pharmaceuticals
Achaogen
Arbutus Biopharma
Altimmune Inc
Bavarian Nordic
Cleveland Biolabs
Emergent Biosolutions Inc
Elusys Therapeutics Inc
Dynport Vaccine Company
Dynavax Technologies Corporation
Hytest
Ichor Medical Systems
GSK
SIGA Technologies
Sanofi
Soligenix
Ology Bioservices
PharmAthene
Xoma Corporation

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Biological Defense Measures 麻豆原创 Size (2020-2031)
2.1.2 Biological Defense Measures 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Biological Defense Measures by Country/Region (2020, 2024 & 2031)
2.2 Biological Defense Measures Segment by Type
2.2.1 Biological
2.2.2 Chemical
2.2.3 Radiological
2.2.4 Nuclear (CBRN) Warfare Agents
2.2.5 Others
2.3 Biological Defense Measures 麻豆原创 Size by Type
2.3.1 Biological Defense Measures 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Biological Defense Measures 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Biological Defense Measures Segment by Application
2.4.1 Medical
2.4.2 Military
2.5 Biological Defense Measures 麻豆原创 Size by Application
2.5.1 Biological Defense Measures 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Biological Defense Measures 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Biological Defense Measures 麻豆原创 Size by Player
3.1 Biological Defense Measures 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Biological Defense Measures Revenue by Player (2020-2025)
3.1.2 Global Biological Defense Measures Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Biological Defense Measures Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biological Defense Measures by Region
4.1 Biological Defense Measures 麻豆原创 Size by Region (2020-2025)
4.2 Global Biological Defense Measures Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biological Defense Measures 麻豆原创 Size Growth (2020-2025)
4.4 APAC Biological Defense Measures 麻豆原创 Size Growth (2020-2025)
4.5 Europe Biological Defense Measures 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Biological Defense Measures 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Biological Defense Measures 麻豆原创 Size by Country (2020-2025)
5.2 Americas Biological Defense Measures 麻豆原创 Size by Type (2020-2025)
5.3 Americas Biological Defense Measures 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biological Defense Measures 麻豆原创 Size by Region (2020-2025)
6.2 APAC Biological Defense Measures 麻豆原创 Size by Type (2020-2025)
6.3 APAC Biological Defense Measures 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biological Defense Measures 麻豆原创 Size by Country (2020-2025)
7.2 Europe Biological Defense Measures 麻豆原创 Size by Type (2020-2025)
7.3 Europe Biological Defense Measures 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biological Defense Measures by Region (2020-2025)
8.2 Middle East & Africa Biological Defense Measures 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Biological Defense Measures 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Biological Defense Measures 麻豆原创 Forecast
10.1 Global Biological Defense Measures Forecast by Region (2026-2031)
10.1.1 Global Biological Defense Measures Forecast by Region (2026-2031)
10.1.2 Americas Biological Defense Measures Forecast
10.1.3 APAC Biological Defense Measures Forecast
10.1.4 Europe Biological Defense Measures Forecast
10.1.5 Middle East & Africa Biological Defense Measures Forecast
10.2 Americas Biological Defense Measures Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Biological Defense Measures Forecast
10.2.2 Canada 麻豆原创 Biological Defense Measures Forecast
10.2.3 Mexico 麻豆原创 Biological Defense Measures Forecast
10.2.4 Brazil 麻豆原创 Biological Defense Measures Forecast
10.3 APAC Biological Defense Measures Forecast by Region (2026-2031)
10.3.1 China Biological Defense Measures 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Biological Defense Measures Forecast
10.3.3 Korea 麻豆原创 Biological Defense Measures Forecast
10.3.4 Southeast Asia 麻豆原创 Biological Defense Measures Forecast
10.3.5 India 麻豆原创 Biological Defense Measures Forecast
10.3.6 Australia 麻豆原创 Biological Defense Measures Forecast
10.4 Europe Biological Defense Measures Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Biological Defense Measures Forecast
10.4.2 France 麻豆原创 Biological Defense Measures Forecast
10.4.3 UK 麻豆原创 Biological Defense Measures Forecast
10.4.4 Italy 麻豆原创 Biological Defense Measures Forecast
10.4.5 Russia 麻豆原创 Biological Defense Measures Forecast
10.5 Middle East & Africa Biological Defense Measures Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Biological Defense Measures Forecast
10.5.2 South Africa 麻豆原创 Biological Defense Measures Forecast
10.5.3 Israel 麻豆原创 Biological Defense Measures Forecast
10.5.4 Turkey 麻豆原创 Biological Defense Measures Forecast
10.6 Global Biological Defense Measures Forecast by Type (2026-2031)
10.7 Global Biological Defense Measures Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Biological Defense Measures Forecast
11 Key Players Analysis
11.1 Alnylam Pharmaceuticals Inc
11.1.1 Alnylam Pharmaceuticals Inc Company Information
11.1.2 Alnylam Pharmaceuticals Inc Biological Defense Measures Product Offered
11.1.3 Alnylam Pharmaceuticals Inc Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Alnylam Pharmaceuticals Inc Main Business Overview
11.1.5 Alnylam Pharmaceuticals Inc Latest Developments
11.2 Aeolus Pharmaceuticals
11.2.1 Aeolus Pharmaceuticals Company Information
11.2.2 Aeolus Pharmaceuticals Biological Defense Measures Product Offered
11.2.3 Aeolus Pharmaceuticals Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Aeolus Pharmaceuticals Main Business Overview
11.2.5 Aeolus Pharmaceuticals Latest Developments
11.3 Achaogen
11.3.1 Achaogen Company Information
11.3.2 Achaogen Biological Defense Measures Product Offered
11.3.3 Achaogen Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Achaogen Main Business Overview
11.3.5 Achaogen Latest Developments
11.4 Arbutus Biopharma
11.4.1 Arbutus Biopharma Company Information
11.4.2 Arbutus Biopharma Biological Defense Measures Product Offered
11.4.3 Arbutus Biopharma Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Arbutus Biopharma Main Business Overview
11.4.5 Arbutus Biopharma Latest Developments
11.5 Altimmune Inc
11.5.1 Altimmune Inc Company Information
11.5.2 Altimmune Inc Biological Defense Measures Product Offered
11.5.3 Altimmune Inc Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Altimmune Inc Main Business Overview
11.5.5 Altimmune Inc Latest Developments
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Information
11.6.2 Bavarian Nordic Biological Defense Measures Product Offered
11.6.3 Bavarian Nordic Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Bavarian Nordic Main Business Overview
11.6.5 Bavarian Nordic Latest Developments
11.7 Cleveland Biolabs
11.7.1 Cleveland Biolabs Company Information
11.7.2 Cleveland Biolabs Biological Defense Measures Product Offered
11.7.3 Cleveland Biolabs Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Cleveland Biolabs Main Business Overview
11.7.5 Cleveland Biolabs Latest Developments
11.8 Emergent Biosolutions Inc
11.8.1 Emergent Biosolutions Inc Company Information
11.8.2 Emergent Biosolutions Inc Biological Defense Measures Product Offered
11.8.3 Emergent Biosolutions Inc Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Emergent Biosolutions Inc Main Business Overview
11.8.5 Emergent Biosolutions Inc Latest Developments
11.9 Elusys Therapeutics Inc
11.9.1 Elusys Therapeutics Inc Company Information
11.9.2 Elusys Therapeutics Inc Biological Defense Measures Product Offered
11.9.3 Elusys Therapeutics Inc Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Elusys Therapeutics Inc Main Business Overview
11.9.5 Elusys Therapeutics Inc Latest Developments
11.10 Dynport Vaccine Company
11.10.1 Dynport Vaccine Company Company Information
11.10.2 Dynport Vaccine Company Biological Defense Measures Product Offered
11.10.3 Dynport Vaccine Company Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Dynport Vaccine Company Main Business Overview
11.10.5 Dynport Vaccine Company Latest Developments
11.11 Dynavax Technologies Corporation
11.11.1 Dynavax Technologies Corporation Company Information
11.11.2 Dynavax Technologies Corporation Biological Defense Measures Product Offered
11.11.3 Dynavax Technologies Corporation Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Dynavax Technologies Corporation Main Business Overview
11.11.5 Dynavax Technologies Corporation Latest Developments
11.12 Hytest
11.12.1 Hytest Company Information
11.12.2 Hytest Biological Defense Measures Product Offered
11.12.3 Hytest Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Hytest Main Business Overview
11.12.5 Hytest Latest Developments
11.13 Ichor Medical Systems
11.13.1 Ichor Medical Systems Company Information
11.13.2 Ichor Medical Systems Biological Defense Measures Product Offered
11.13.3 Ichor Medical Systems Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Ichor Medical Systems Main Business Overview
11.13.5 Ichor Medical Systems Latest Developments
11.14 GSK
11.14.1 GSK Company Information
11.14.2 GSK Biological Defense Measures Product Offered
11.14.3 GSK Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 GSK Main Business Overview
11.14.5 GSK Latest Developments
11.15 SIGA Technologies
11.15.1 SIGA Technologies Company Information
11.15.2 SIGA Technologies Biological Defense Measures Product Offered
11.15.3 SIGA Technologies Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 SIGA Technologies Main Business Overview
11.15.5 SIGA Technologies Latest Developments
11.16 Sanofi
11.16.1 Sanofi Company Information
11.16.2 Sanofi Biological Defense Measures Product Offered
11.16.3 Sanofi Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Sanofi Main Business Overview
11.16.5 Sanofi Latest Developments
11.17 Soligenix
11.17.1 Soligenix Company Information
11.17.2 Soligenix Biological Defense Measures Product Offered
11.17.3 Soligenix Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Soligenix Main Business Overview
11.17.5 Soligenix Latest Developments
11.18 Ology Bioservices
11.18.1 Ology Bioservices Company Information
11.18.2 Ology Bioservices Biological Defense Measures Product Offered
11.18.3 Ology Bioservices Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Ology Bioservices Main Business Overview
11.18.5 Ology Bioservices Latest Developments
11.19 PharmAthene
11.19.1 PharmAthene Company Information
11.19.2 PharmAthene Biological Defense Measures Product Offered
11.19.3 PharmAthene Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 PharmAthene Main Business Overview
11.19.5 PharmAthene Latest Developments
11.20 Xoma Corporation
11.20.1 Xoma Corporation Company Information
11.20.2 Xoma Corporation Biological Defense Measures Product Offered
11.20.3 Xoma Corporation Biological Defense Measures Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Xoma Corporation Main Business Overview
11.20.5 Xoma Corporation Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.